HEADER ANTAGONIST 28-JUL-95 1BDK TITLE AN NMR, CD, MOLECULAR DYNAMICS, AND FLUOROMETRIC STUDY OF THE TITLE 2 CONFORMATION OF THE BRADYKININ ANTAGONIST B-9340 IN WATER AND IN TITLE 3 AQUEOUS MICELLAR SOLUTIONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: BRADYKININ ANTAGONIST B-9340; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS BRADYKININ ANTAGONIST, ANTAGONIST EXPDTA SOLUTION NMR AUTHOR J.SEJBAL,G.KOTOVYCH,J.R.CANN,J.M.STEWART,L.GERA REVDAT 4 05-JUN-24 1BDK 1 REMARK LINK REVDAT 3 13-JUL-11 1BDK 1 VERSN REVDAT 2 24-FEB-09 1BDK 1 VERSN REVDAT 1 07-DEC-95 1BDK 0 JRNL AUTH J.SEJBAL,J.R.CANN,J.M.STEWART,L.GERA,G.KOTOVYCH JRNL TITL AN NMR, CD, MOLECULAR DYNAMICS, AND FLUOROMETRIC STUDY OF JRNL TITL 2 THE CONFORMATION OF THE BRADYKININ ANTAGONIST B-9340 IN JRNL TITL 3 WATER AND IN AQUEOUS MICELLAR SOLUTIONS. JRNL REF J.MED.CHEM. V. 39 1281 1996 JRNL REFN ISSN 0022-2623 JRNL PMID 8632435 JRNL DOI 10.1021/JM950485F REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.GUBA,R.HAESSNER,G.BREIPOHL,S.HENKE,J.KNOLLE,V.SANTAGADA, REMARK 1 AUTH 2 H.KESSLER REMARK 1 TITL COMBINED APPROACH OF NMR AND MOLECULAR DYNAMICS WITHIN A REMARK 1 TITL 2 BIPHASIC MEMBRANE MIMETICS: CONFORMATION AND ORIENTATION OF REMARK 1 TITL 3 THE BRADYKININ ANTAGONIST HOE 140 REMARK 1 REF J.AM.CHEM.SOC. V. 116 7532 1994 REMARK 1 REFN ISSN 0002-7863 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BIOGRAF REMARK 3 AUTHORS : MOLECULAR SIMULATIONS,INC REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BDK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171626. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DAR A 1 NE - CZ - NH1 ANGL. DEV. = 7.9 DEGREES REMARK 500 DAR A 1 NE - CZ - NH2 ANGL. DEV. = -6.9 DEGREES REMARK 500 ARG A 2 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 ARG A 2 NE - CZ - NH2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ARG A 10 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 10 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 3 104.86 -32.35 REMARK 500 TIH A 6 119.46 173.60 REMARK 500 IGL A 8 -157.12 81.17 REMARK 500 OIC A 9 59.25 -93.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 5 TIH A 6 149.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DAR A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OIC A 9 DBREF 1BDK A 1 10 PDB 1BDK 1BDK 1 10 SEQRES 1 A 10 DAR ARG PRO HYP GLY TIH SER IGL OIC ARG MODRES 1BDK HYP A 4 PRO 4-HYDROXYPROLINE MODRES 1BDK TIH A 6 ALA BETA(2-THIENYL)ALANINE MODRES 1BDK IGL A 8 GLY ALPHA-AMINO-2-INDANACETIC ACID HET DAR A 1 26 HET HYP A 4 15 HET TIH A 6 17 HET IGL A 8 24 HET OIC A 9 24 HETNAM DAR D-ARGININE HETNAM HYP 4-HYDROXYPROLINE HETNAM TIH BETA(2-THIENYL)ALANINE HETNAM IGL ALPHA-AMINO-2-INDANACETIC ACID HETNAM OIC OCTAHYDROINDOLE-2-CARBOXYLIC ACID HETSYN HYP HYDROXYPROLINE FORMUL 1 DAR C6 H15 N4 O2 1+ FORMUL 1 HYP C5 H9 N O3 FORMUL 1 TIH C7 H9 N O2 S FORMUL 1 IGL C11 H13 N O2 FORMUL 1 OIC C9 H15 N O2 LINK C DAR A 1 N ARG A 2 1555 1555 1.36 LINK C PRO A 3 N HYP A 4 1555 1555 1.37 LINK C HYP A 4 N GLY A 5 1555 1555 1.34 LINK C GLY A 5 N TIH A 6 1555 1555 1.35 LINK C TIH A 6 N SER A 7 1555 1555 1.36 LINK C SER A 7 N IGL A 8 1555 1555 1.35 LINK C IGL A 8 N OIC A 9 1555 1555 1.38 LINK C OIC A 9 N ARG A 10 1555 1555 1.36 SITE 1 AC1 2 ARG A 2 PRO A 3 SITE 1 AC2 3 TIH A 6 SER A 7 IGL A 8 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 HETATM 1 N DAR A 1 2.926 -5.879 -6.718 1.00 0.00 N HETATM 2 CA DAR A 1 1.873 -6.196 -5.715 1.00 0.00 C HETATM 3 CB DAR A 1 0.674 -6.777 -6.518 1.00 0.00 C HETATM 4 CG DAR A 1 -0.485 -7.382 -5.667 1.00 0.00 C HETATM 5 CD DAR A 1 -0.099 -8.646 -4.858 1.00 0.00 C HETATM 6 NE DAR A 1 -1.289 -9.163 -4.264 1.00 0.00 N HETATM 7 CZ DAR A 1 -1.681 -9.128 -2.986 1.00 0.00 C HETATM 8 NH1 DAR A 1 -1.044 -8.602 -1.946 1.00 0.00 N HETATM 9 NH2 DAR A 1 -2.852 -9.695 -2.783 1.00 0.00 N HETATM 10 C DAR A 1 1.538 -4.977 -4.917 1.00 0.00 C HETATM 11 O DAR A 1 1.241 -3.938 -5.559 1.00 0.00 O HETATM 12 H1 DAR A 1 2.653 -5.053 -7.264 1.00 0.00 H HETATM 13 H2 DAR A 1 3.813 -5.657 -6.253 1.00 0.00 H HETATM 14 H3 DAR A 1 3.088 -6.637 -7.375 1.00 0.00 H HETATM 15 HA DAR A 1 2.265 -6.960 -5.035 1.00 0.00 H HETATM 16 HB2 DAR A 1 0.280 -5.971 -7.151 1.00 0.00 H HETATM 17 HB3 DAR A 1 1.046 -7.555 -7.196 1.00 0.00 H HETATM 18 HG2 DAR A 1 -0.895 -6.636 -4.977 1.00 0.00 H HETATM 19 HG3 DAR A 1 -1.304 -7.655 -6.345 1.00 0.00 H HETATM 20 HD2 DAR A 1 0.336 -9.407 -5.515 1.00 0.00 H HETATM 21 HD3 DAR A 1 0.644 -8.416 -4.095 1.00 0.00 H HETATM 22 HE DAR A 1 -1.948 -9.590 -4.824 1.00 0.00 H HETATM 23 HH11 DAR A 1 -0.183 -8.193 -2.046 1.00 0.00 H HETATM 24 HH12 DAR A 1 -1.416 -8.685 -1.063 1.00 0.00 H HETATM 25 HH21 DAR A 1 -3.278 -10.092 -3.546 1.00 0.00 H HETATM 26 HH22 DAR A 1 -3.255 -9.688 -1.910 1.00 0.00 H